CardioFuture

MedTech, Cardio, Dental and OrthoFuture blog pages help you stay on top of the latest news in the medical device industries.

Helping you stay on top of the latest developments in the cardiovascular industry.

MedTech, Cardio, Dental and OrthoFuture blog pages help you stay on top of the latest news in the medical device industries.

Helping you stay on top of the latest developments in the cardiovascular industry.

Stay Up-to-Date with our Monthly CardioFuture Newsletter

SUBSCRIBE

Stay Up-to-Date with our Monthly CardioFuture Newsletter

SUBSCRIBE
Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Implantation (TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19.
Cardiology, Vascular Access

Top European TAVR Companies

November 27, 2020
Based on the latest market analysis by iData Research, the European Transcatheter Aortic Valve Replacement (also known as TAVR/TAVI) market was valued at €836.2 million in 2020, which is a 29% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace the diseased aortic valve in patients with severe aortic stenosis. ......
Azure™ with BlueSync™ Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring
Cardiac Rhythm Management, Cardiology

Medtronic’s Newest Form of Communication with the Heart

November 17, 2020
Medtronic has released its first-ever app-connected pacemaker called Azure. A pacemaker is an implantable device designed to regulate the electrical impulses of the heart. They are used to correct uneven heartbeats. Millions of patients have pacemaker implants to treat arrhythmia or heart failure. However, many patients do not understand how these devices function. This smartphone-connected......
Articles, Cardiac Surgery, Cardiology

Over 182,000 Heart Valve Replacements Per Year in the United States

November 13, 2020
According to the latest Cardiac Surgery market study by iData Research, over 182,000 heart valve replacements are performed every year in the United States. Heart valve replacements are one of the most common procedures performed in cardiac surgery market, and they make up nearly a quarter of the total procedure volume. Heart valve replacement procedures......
Syringe, medical injection in hand, palm or fingers. Medicine plastic vaccination equipment with needle. Nurse or doctor. Liquid drug or narcotic. Health care in hospital.
Cardiology, Vascular Access

Top 3 Syringe and Needle Companies in the United States

November 9, 2020
As we progress through the global pandemic and drive closer to having a vaccine available, companies are now preparing supplies such as needles and syringes. We have compiled the top three companies to watch as distributors for needles and syringes in the United States. Becton Dickinson  Cardinal Health Novo Nordisk Becton Dickinson Becton Dickinson produces......
Transcatheter Aortic Valve Replacement (TAVR) market
Cardiac Surgery, Cardiology

FDA Approval of TAVR in Low-Risk Patients Set to Drive Market Growth

November 6, 2020
Register to receive a free TAVR Market Report Suite for the US 2020-2026 synopsis Based on the latest market analysis by iData Research, the Transcatheter Aortic Valve Replacement (TAVR) market was valued at $2,424 million in 2020, which is a 13% decline from 2019 due to COVID19. TAVR is a minimally invasive procedure to replace......
Large Volume Infusion Pump
Cardiology, Infusion Therapy

Best-Selling Large Volume Infusion Pumps in the United States

November 4, 2020
Based on the latest market study by iData Research, the US infusion pump market was valued at almost $1,176 million in 2019. However, due to COVID, the market size is expected to shrink by an astonishing 51% and reach a valuation of $572 million in 2020, before rebounding in 2021. The infusion pump market is......
Articles, Cardiology, Interventional Cardiology

Over 965,000 Angioplasties (PCIs) are Performed Each Year in the United States

October 7, 2020
According to the latest interventional cardiology procedural analysis by iData Research, over 965,000 angioplasties are performed each year in the United States. An angioplasty, also known as percutaneous coronary intervention (PCI), is a procedure that involves stent placement to open blocked or narrowing arteries. Interventional cardiology is primarily applied to the treatment of coronary artery......
Teleflex-Arrow-EZ-IO-300x265
Cardiology, COVID-19, Vascular Access

Teleflex Announces Expanded Indications For Intraosseous Vascular Access System

October 2, 2020
Teleflex has announced its receival of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the indications for the use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device is used to provide procedural guidance within the establishment of intraosseous vascular access, especially when intravenous access is difficult to obtain in......
COVID-19 Causes a Significant Drop in Interventional Cardiology Procedure Numbers
Cardiology, COVID-19, Interventional Cardiology

COVID-19 Causes Significant Drop in Interventional Cardiology Procedure Numbers

September 25, 2020
Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. These procedures allow the heart to continue functioning at its best moving almost 3,000 gallons of blood every day. Based on the European Heart Journal, cardiovascular disease (CVD)......
Investigational Intrepid™ Transcatheter Valve System
Cardiac Surgery, Cardiology

FDA Grants Medtronic Breakthrough Device Designation for Transcatheter Valve System

September 17, 2020
The FDA Breakthrough Devices Program enables manufacturers to streamline the market clearance/approval process for specific medical devices. Medtronic received the breakthrough device designation for its investigational Intrepid™ transcatheter tricuspid valve replacement (TTVR) system. The FDA has also approved an early feasibility study for the device. The new TTVR system will help treat tricuspid valve regurgitation,......
Fitbit Used to Track COVID-19 Symptoms Remotely
Cardiac Rhythm Management, COVID-19, Diagnostics, Patient Monitoring

Fitbit Used for Early Detection of COVID-19 Symptoms

August 28, 2020
Currently, the demand for healthcare workers and facilities is extraordinarily high in areas heavily affected by COVID-19. The demand for patient monitoring devices is also high. One of the biggest challenges in reducing the spread of the virus is contact tracing, which is made difficult through a high demand for health personnel, and because of......
Philips Launches Two Portable Biomedical Products In US
Cardiac Rhythm Management, Cardiology, Diagnostics, Interventional Cardiology, Patient Monitoring

Philips Launches Two Portable Biomedical Products In US

August 7, 2020
Philips has announced the launch of two portable biomedical products, after obtaining FDA approval for them: the Tempus ALS and Tempus Pro. Both of the devices are designed for use with Philips’ Intellispace Corsium software. This web-based platform is used to record and upload data real-time, and it can be used for communication. This adds......
New Cardiac Monitor Using Nanogenerators Powered by Human Body
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

New Cardiac Monitor Uses Nanogenerators Powered by Human Body

August 6, 2020
Researchers at Purdue University have been developing a wearable cardiac monitor that functions by harvesting the energy of the human body. The device uses TENG’s, triboelectric nanogenerators, with polyvinyl alcohol-based contact layers, to monitor cardiac health. If further research shows this technology is viable, this could be a major step forward for all patient monitoring......
Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms

August 5, 2020
The FDA has granted Emergency Use Authorization to Abiomed for their left-sided Impella heart pumps. These pumps are used to support patients during heart failure and provide left ventricular unloading. The long-term effects of COVID-19 are not yet well-understood. Initially, the most focus was placed on respiratory issues and lung damage, which were the most......
Boston Scientific Granted FDA Approval for Stroke Prevention Device
Cardiac Rhythm Management, Cardiology, Interventional Cardiology

Boston Scientific Granted FDA Approval for Stroke Prevention Device

August 4, 2020
According to iData’s latest Interventional Cardiology market report, Boston Scientific is the leading competitor in this market. Now, they have produced another innovative interventional cardiology device. The FDA has recently approved Boston Scientific’s stroke prevention device, the Watchman FLX, making it available for sale in the US. This device follows the original edition of the......
Medtronic receives CE mark for Micra AV Pacemaker
Cardiac Rhythm Management, Cardiology, Diagnostics, Interventional Cardiology, Patient Monitoring

Medtronic receives CE mark for Micra AV Pacemaker

July 8, 2020
Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaired neural signals between atrial and ventricular chambers in the heart. AV block can lead to irregular beat, and in some cases, increased risk......
Boston Scientific Given FDA 510(k) Clearance for Insertable Cardiac Monitor System
Cardiac Rhythm Management, Cardiology, Diagnostics, Patient Monitoring

Boston Scientific Given FDA 510(k) Clearance for Insertable Cardiac Monitor System

July 8, 2020
Boston Scientific has been granted FDA 510(k) clearance for their LUX-Dx insertable cardiac monitor system. This long-term diagnostic device is used to detect arrhythmias from conditions such as atrial fibrillation, syncope, and cryptogenic stroke. The LUX-Dx’s multi-stage algorithm first detects potential arrhythmias, then verifies them. When an arrhythmia is verified, clinicians are immediately alerted, so......
Articles, Atherectomy, Cardiology, COVID-19 Industry Insights, Peripheral Vascular

Atherectomy Market is Heating Up: Strong Growth and Increasing Competition

July 6, 2020
According to the latest market analysis by iData Research, the U.S. atherectomy market is expected to remain as one of the biggest contributors to the growth of the peripheral vascular market. While often performed in conjunction with other procedures, such as angioplasties, atherectomy procedures have been experiencing double-digit growth rates for the past two years......
Lithotripsy Procedure Equipment
Articles, Cardiology, COVID-19 Industry Insights, Lithotripsy, Peripheral Vascular

Over 24,000 Intravascular Lithotripsy Procedures to be Performed by 2026 in the US

July 3, 2020
According to the latest market analysis by iData Research, there are over 12,000 intravascular lithotripsy procedures performed in the United States every year. This number is expected to experience incredible growth and double in number by 2026. This growth can be attributed to two main factors: the creation of procedure codes by CMS, and successful......
FDA Grants Emergency Use Authorization for Abiomed Impella RP
Cardiac Surgery, Cardiology, COVID-19, Interventional Cardiology

FDA Grants Emergency Use Authorization to Abiomed for Impella RP

June 5, 2020
Abiomed has been granted FDA emergency use authorization for its Impella RP – a temporary heart pump to support circulatory system functioning in patients with right side ventricular failure. The FDA has granted EUA for this device to treat COVID-19 patients, as some of them have suffered from right heart failure due to the virus,......
Articles, Cardiology, COVID-19 Industry Insights, Vascular Access

Over 2.7 million PICC line insertion procedures are performed each year in the United States

June 2, 2020
According to the latest vascular access device market analysis by iData Research, there are over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year in the United States. The overall US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. PICC insertions......
US Vascular Access Catheter and Accessories markets
Articles, Cardiology, COVID-19 Industry Insights, Vascular Access

PICC, CVC, and PIVC insertion accessories are driving market growth in the United States

May 28, 2020
According to the latest market analysis by iData Research, the US vascular access market was valued at $4.8 billion by 2020 and is expected to reach $5.7 billion in 2026. One of the biggest contributors to this growth will be the PICC, CVC, and PIVC line insertion and securement accessories market. This market growth is primarily......
Terumo Aortic gains FDA breakthrough status for new aortic repair device
Cardiac Surgery, Cardiology, Interventional Cardiology

Terumo Aortic Gains FDA Breakthrough Status for Aortic Repair Device

May 6, 2020
Terumo Aortic, a company that focuses exclusively on producing devices regarding aorta, has developed the Thoraflex Hybrid to aid patients who have suffered from a thoracic aortic aneurysm, or a tear in the aortic vessel wall. These conditions are often fatal, and have low survival rates, even when patients receive prompt medical care. The device......
Lungpacer Medical gains FDA approval for diaphragm pacer therapy system
Cardiology, COVID-19, Respiratory Devices

Lungpacer Medical Gains FDA Approval for Diaphragm Pacer

May 5, 2020
Vancouver-based company Lungpacer Medical has developed a single-use multi-electrode stimulating catheter that is inserted into the left subclavicle vein. It is used to stimulate the left and right phrenic nerves, providing support to the functioning of the diaphragm in patients who have respiratory issues. The device is paired with an external, reusable control unit to......
CMS Recommends Reopening Healthcare in Areas of Low COVID-19 Cases
Cardiology, COVID-19, Dental, Endoscopy, Orthopedics

CMS Recommends Reopening Healthcare in Areas of Low COVID-19 Cases

April 21, 2020
The Center for Medicare and Medicaid Services (CMS) is reissuing new guidelines for states and regions seeing declining and stabilizing COVID-19 infection rates and recommending healthcare facilities in these areas to resume providing elective procedures to patients without COVID-19 symptoms. On March 18, 2020, the CMS announced they would postponing non-essential medical and surgical procedures......
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link

close-link